nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—CYP2C8—Sorafenib—liver cancer	0.0824	0.426	CbGbCtD
Montelukast—CYP2C9—Sorafenib—liver cancer	0.0575	0.297	CbGbCtD
Montelukast—CYP3A4—Sorafenib—liver cancer	0.0334	0.173	CbGbCtD
Montelukast—CYP3A4—Doxorubicin—liver cancer	0.0203	0.105	CbGbCtD
Montelukast—Leukocytoclastic vasculitis—Sorafenib—liver cancer	0.0132	0.0338	CcSEcCtD
Montelukast—Suicide—Sorafenib—liver cancer	0.0125	0.032	CcSEcCtD
Montelukast—Completed suicide—Sorafenib—liver cancer	0.011	0.0282	CcSEcCtD
Montelukast—Rhinorrhoea—Sorafenib—liver cancer	0.00798	0.0205	CcSEcCtD
Montelukast—Bone disorder—Sorafenib—liver cancer	0.00716	0.0184	CcSEcCtD
Montelukast—Neuropathy—Sorafenib—liver cancer	0.00607	0.0156	CcSEcCtD
Montelukast—Erythema nodosum—Epirubicin—liver cancer	0.00552	0.0142	CcSEcCtD
Montelukast—Eczema—Sorafenib—liver cancer	0.00522	0.0134	CcSEcCtD
Montelukast—Erythema nodosum—Doxorubicin—liver cancer	0.00511	0.0131	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Sorafenib—liver cancer	0.00422	0.0109	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.00422	0.0109	CcSEcCtD
Montelukast—Nasopharyngitis—Sorafenib—liver cancer	0.0042	0.0108	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Sorafenib—liver cancer	0.00414	0.0106	CcSEcCtD
Montelukast—Pancreatitis—Sorafenib—liver cancer	0.00398	0.0102	CcSEcCtD
Montelukast—Pneumonia—Sorafenib—liver cancer	0.00364	0.00934	CcSEcCtD
Montelukast—Infestation NOS—Sorafenib—liver cancer	0.00362	0.00929	CcSEcCtD
Montelukast—Infestation—Sorafenib—liver cancer	0.00362	0.00929	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.00358	0.00921	CcSEcCtD
Montelukast—Neuropathy peripheral—Sorafenib—liver cancer	0.00354	0.0091	CcSEcCtD
Montelukast—Jaundice—Sorafenib—liver cancer	0.00352	0.00905	CcSEcCtD
Montelukast—Hepatobiliary disease—Sorafenib—liver cancer	0.00342	0.00878	CcSEcCtD
Montelukast—Epistaxis—Sorafenib—liver cancer	0.00341	0.00876	CcSEcCtD
Montelukast—Laryngitis—Epirubicin—liver cancer	0.00331	0.00851	CcSEcCtD
Montelukast—Dermatitis atopic—Epirubicin—liver cancer	0.00323	0.00829	CcSEcCtD
Montelukast—Urinary tract disorder—Sorafenib—liver cancer	0.00321	0.00823	CcSEcCtD
Montelukast—Connective tissue disorder—Sorafenib—liver cancer	0.00319	0.00819	CcSEcCtD
Montelukast—Urethral disorder—Sorafenib—liver cancer	0.00318	0.00817	CcSEcCtD
Montelukast—Erythema multiforme—Sorafenib—liver cancer	0.00307	0.00788	CcSEcCtD
Montelukast—Otitis media—Epirubicin—liver cancer	0.00307	0.00788	CcSEcCtD
Montelukast—Laryngitis—Doxorubicin—liver cancer	0.00307	0.00788	CcSEcCtD
Montelukast—Cardiac disorder—Sorafenib—liver cancer	0.00301	0.00774	CcSEcCtD
Montelukast—Dermatitis atopic—Doxorubicin—liver cancer	0.00299	0.00767	CcSEcCtD
Montelukast—Immune system disorder—Sorafenib—liver cancer	0.00293	0.00753	CcSEcCtD
Montelukast—Mediastinal disorder—Sorafenib—liver cancer	0.00293	0.00751	CcSEcCtD
Montelukast—Mental disorder—Sorafenib—liver cancer	0.00284	0.0073	CcSEcCtD
Montelukast—Otitis media—Doxorubicin—liver cancer	0.00284	0.00729	CcSEcCtD
Montelukast—Liver injury—Epirubicin—liver cancer	0.00284	0.00729	CcSEcCtD
Montelukast—Muscle spasms—Sorafenib—liver cancer	0.00272	0.00698	CcSEcCtD
Montelukast—Viral infection—Epirubicin—liver cancer	0.00264	0.00679	CcSEcCtD
Montelukast—Bone disorder—Epirubicin—liver cancer	0.00264	0.00679	CcSEcCtD
Montelukast—Liver injury—Doxorubicin—liver cancer	0.00263	0.00675	CcSEcCtD
Montelukast—Angioedema—Sorafenib—liver cancer	0.00258	0.00663	CcSEcCtD
Montelukast—Cough—Sorafenib—liver cancer	0.00247	0.00633	CcSEcCtD
Montelukast—Viral infection—Doxorubicin—liver cancer	0.00245	0.00628	CcSEcCtD
Montelukast—Bone disorder—Doxorubicin—liver cancer	0.00245	0.00628	CcSEcCtD
Montelukast—Arthralgia—Sorafenib—liver cancer	0.00241	0.00618	CcSEcCtD
Montelukast—Myalgia—Sorafenib—liver cancer	0.00241	0.00618	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00239	0.00614	CcSEcCtD
Montelukast—Hepatocellular injury—Epirubicin—liver cancer	0.00239	0.00614	CcSEcCtD
Montelukast—Anaphylactic shock—Sorafenib—liver cancer	0.00231	0.00592	CcSEcCtD
Montelukast—Infection—Sorafenib—liver cancer	0.00229	0.00588	CcSEcCtD
Montelukast—Nervous system disorder—Sorafenib—liver cancer	0.00226	0.00581	CcSEcCtD
Montelukast—Thrombocytopenia—Sorafenib—liver cancer	0.00226	0.0058	CcSEcCtD
Montelukast—Neuropathy—Epirubicin—liver cancer	0.00224	0.00576	CcSEcCtD
Montelukast—Skin disorder—Sorafenib—liver cancer	0.00224	0.00575	CcSEcCtD
Montelukast—Hepatocellular injury—Doxorubicin—liver cancer	0.00221	0.00568	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Sorafenib—liver cancer	0.0021	0.0054	CcSEcCtD
Montelukast—Neuropathy—Doxorubicin—liver cancer	0.00208	0.00533	CcSEcCtD
Montelukast—Dyspepsia—Sorafenib—liver cancer	0.00203	0.00521	CcSEcCtD
Montelukast—Gastrointestinal disorder—Sorafenib—liver cancer	0.00199	0.00511	CcSEcCtD
Montelukast—Fatigue—Sorafenib—liver cancer	0.00199	0.00511	CcSEcCtD
Montelukast—Pain—Sorafenib—liver cancer	0.00197	0.00506	CcSEcCtD
Montelukast—Eczema—Epirubicin—liver cancer	0.00193	0.00496	CcSEcCtD
Montelukast—Gastrointestinal pain—Sorafenib—liver cancer	0.00189	0.00484	CcSEcCtD
Montelukast—Urticaria—Sorafenib—liver cancer	0.00183	0.00471	CcSEcCtD
Montelukast—Body temperature increased—Sorafenib—liver cancer	0.00182	0.00468	CcSEcCtD
Montelukast—Abdominal pain—Sorafenib—liver cancer	0.00182	0.00468	CcSEcCtD
Montelukast—Eczema—Doxorubicin—liver cancer	0.00179	0.00459	CcSEcCtD
Montelukast—Hypersensitivity—Sorafenib—liver cancer	0.0017	0.00436	CcSEcCtD
Montelukast—Asthenia—Sorafenib—liver cancer	0.00165	0.00425	CcSEcCtD
Montelukast—Pruritus—Sorafenib—liver cancer	0.00163	0.00419	CcSEcCtD
Montelukast—Diarrhoea—Sorafenib—liver cancer	0.00158	0.00405	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00156	0.00401	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00156	0.00401	CcSEcCtD
Montelukast—Nasopharyngitis—Epirubicin—liver cancer	0.00155	0.00398	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Epirubicin—liver cancer	0.00153	0.00393	CcSEcCtD
Montelukast—Dizziness—Sorafenib—liver cancer	0.00152	0.00392	CcSEcCtD
Montelukast—Asthma—Epirubicin—liver cancer	0.0015	0.00385	CcSEcCtD
Montelukast—Influenza—Epirubicin—liver cancer	0.0015	0.00385	CcSEcCtD
Montelukast—Eosinophilia—Epirubicin—liver cancer	0.00148	0.00381	CcSEcCtD
Montelukast—Pancreatitis—Epirubicin—liver cancer	0.00147	0.00377	CcSEcCtD
Montelukast—Vomiting—Sorafenib—liver cancer	0.00147	0.00377	CcSEcCtD
Montelukast—Rash—Sorafenib—liver cancer	0.00145	0.00373	CcSEcCtD
Montelukast—Dermatitis—Sorafenib—liver cancer	0.00145	0.00373	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00144	0.00371	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00144	0.00371	CcSEcCtD
Montelukast—Headache—Sorafenib—liver cancer	0.00144	0.00371	CcSEcCtD
Montelukast—Bronchitis—Epirubicin—liver cancer	0.00144	0.0037	CcSEcCtD
Montelukast—Nasopharyngitis—Doxorubicin—liver cancer	0.00143	0.00368	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.00142	0.00363	CcSEcCtD
Montelukast—Upper respiratory tract infection—Epirubicin—liver cancer	0.00139	0.00358	CcSEcCtD
Montelukast—Asthma—Doxorubicin—liver cancer	0.00139	0.00356	CcSEcCtD
Montelukast—Influenza—Doxorubicin—liver cancer	0.00139	0.00356	CcSEcCtD
Montelukast—Eosinophilia—Doxorubicin—liver cancer	0.00137	0.00353	CcSEcCtD
Montelukast—Nausea—Sorafenib—liver cancer	0.00137	0.00352	CcSEcCtD
Montelukast—Pancreatitis—Doxorubicin—liver cancer	0.00136	0.00349	CcSEcCtD
Montelukast—Pneumonia—Epirubicin—liver cancer	0.00134	0.00345	CcSEcCtD
Montelukast—Infestation NOS—Epirubicin—liver cancer	0.00134	0.00343	CcSEcCtD
Montelukast—Infestation—Epirubicin—liver cancer	0.00134	0.00343	CcSEcCtD
Montelukast—Drowsiness—Epirubicin—liver cancer	0.00134	0.00343	CcSEcCtD
Montelukast—Bronchitis—Doxorubicin—liver cancer	0.00133	0.00343	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00132	0.0034	CcSEcCtD
Montelukast—Neuropathy peripheral—Epirubicin—liver cancer	0.00131	0.00336	CcSEcCtD
Montelukast—Jaundice—Epirubicin—liver cancer	0.0013	0.00335	CcSEcCtD
Montelukast—Conjunctivitis—Epirubicin—liver cancer	0.0013	0.00334	CcSEcCtD
Montelukast—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00129	0.00331	CcSEcCtD
Montelukast—Hepatobiliary disease—Epirubicin—liver cancer	0.00126	0.00325	CcSEcCtD
Montelukast—Epistaxis—Epirubicin—liver cancer	0.00126	0.00324	CcSEcCtD
Montelukast—Sinusitis—Epirubicin—liver cancer	0.00125	0.00322	CcSEcCtD
Montelukast—Pneumonia—Doxorubicin—liver cancer	0.00124	0.00319	CcSEcCtD
Montelukast—Infestation—Doxorubicin—liver cancer	0.00124	0.00318	CcSEcCtD
Montelukast—Drowsiness—Doxorubicin—liver cancer	0.00124	0.00318	CcSEcCtD
Montelukast—Infestation NOS—Doxorubicin—liver cancer	0.00124	0.00318	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00123	0.00315	CcSEcCtD
Montelukast—Neuropathy peripheral—Doxorubicin—liver cancer	0.00121	0.00311	CcSEcCtD
Montelukast—Jaundice—Doxorubicin—liver cancer	0.00121	0.0031	CcSEcCtD
Montelukast—Rhinitis—Epirubicin—liver cancer	0.0012	0.00309	CcSEcCtD
Montelukast—Conjunctivitis—Doxorubicin—liver cancer	0.0012	0.00309	CcSEcCtD
Montelukast—Hepatitis—Epirubicin—liver cancer	0.0012	0.00308	CcSEcCtD
Montelukast—Hypoaesthesia—Epirubicin—liver cancer	0.00119	0.00307	CcSEcCtD
Montelukast—Pharyngitis—Epirubicin—liver cancer	0.00119	0.00306	CcSEcCtD
Montelukast—Urinary tract disorder—Epirubicin—liver cancer	0.00118	0.00304	CcSEcCtD
Montelukast—Connective tissue disorder—Epirubicin—liver cancer	0.00118	0.00303	CcSEcCtD
Montelukast—Urethral disorder—Epirubicin—liver cancer	0.00118	0.00302	CcSEcCtD
Montelukast—Hepatobiliary disease—Doxorubicin—liver cancer	0.00117	0.003	CcSEcCtD
Montelukast—Epistaxis—Doxorubicin—liver cancer	0.00117	0.003	CcSEcCtD
Montelukast—Sinusitis—Doxorubicin—liver cancer	0.00116	0.00298	CcSEcCtD
Montelukast—Erythema multiforme—Epirubicin—liver cancer	0.00113	0.00291	CcSEcCtD
Montelukast—Cardiac disorder—Epirubicin—liver cancer	0.00111	0.00286	CcSEcCtD
Montelukast—Rhinitis—Doxorubicin—liver cancer	0.00111	0.00286	CcSEcCtD
Montelukast—Hepatitis—Doxorubicin—liver cancer	0.00111	0.00285	CcSEcCtD
Montelukast—Hypoaesthesia—Doxorubicin—liver cancer	0.0011	0.00284	CcSEcCtD
Montelukast—Pharyngitis—Doxorubicin—liver cancer	0.0011	0.00283	CcSEcCtD
Montelukast—Urinary tract disorder—Doxorubicin—liver cancer	0.0011	0.00282	CcSEcCtD
Montelukast—Connective tissue disorder—Doxorubicin—liver cancer	0.00109	0.0028	CcSEcCtD
Montelukast—Urethral disorder—Doxorubicin—liver cancer	0.00109	0.00279	CcSEcCtD
Montelukast—Immune system disorder—Epirubicin—liver cancer	0.00108	0.00278	CcSEcCtD
Montelukast—Mediastinal disorder—Epirubicin—liver cancer	0.00108	0.00278	CcSEcCtD
Montelukast—Mental disorder—Epirubicin—liver cancer	0.00105	0.0027	CcSEcCtD
Montelukast—Erythema multiforme—Doxorubicin—liver cancer	0.00105	0.0027	CcSEcCtD
Montelukast—Cardiac disorder—Doxorubicin—liver cancer	0.00103	0.00265	CcSEcCtD
Montelukast—Muscle spasms—Epirubicin—liver cancer	0.001	0.00258	CcSEcCtD
Montelukast—Immune system disorder—Doxorubicin—liver cancer	0.001	0.00257	CcSEcCtD
Montelukast—Mediastinal disorder—Doxorubicin—liver cancer	0.001	0.00257	CcSEcCtD
Montelukast—Mental disorder—Doxorubicin—liver cancer	0.000972	0.0025	CcSEcCtD
Montelukast—Agitation—Epirubicin—liver cancer	0.00096	0.00246	CcSEcCtD
Montelukast—Muscle spasms—Doxorubicin—liver cancer	0.000929	0.00239	CcSEcCtD
Montelukast—Palpitations—Epirubicin—liver cancer	0.000923	0.00237	CcSEcCtD
Montelukast—Cough—Epirubicin—liver cancer	0.000911	0.00234	CcSEcCtD
Montelukast—Convulsion—Epirubicin—liver cancer	0.000905	0.00232	CcSEcCtD
Montelukast—Myalgia—Epirubicin—liver cancer	0.000889	0.00228	CcSEcCtD
Montelukast—Arthralgia—Epirubicin—liver cancer	0.000889	0.00228	CcSEcCtD
Montelukast—Agitation—Doxorubicin—liver cancer	0.000888	0.00228	CcSEcCtD
Montelukast—Anxiety—Epirubicin—liver cancer	0.000886	0.00228	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000883	0.00227	CcSEcCtD
Montelukast—Palpitations—Doxorubicin—liver cancer	0.000854	0.00219	CcSEcCtD
Montelukast—Anaphylactic shock—Epirubicin—liver cancer	0.000852	0.00219	CcSEcCtD
Montelukast—Oedema—Epirubicin—liver cancer	0.000852	0.00219	CcSEcCtD
Montelukast—Infection—Epirubicin—liver cancer	0.000847	0.00217	CcSEcCtD
Montelukast—Cough—Doxorubicin—liver cancer	0.000843	0.00217	CcSEcCtD
Montelukast—Convulsion—Doxorubicin—liver cancer	0.000837	0.00215	CcSEcCtD
Montelukast—Nervous system disorder—Epirubicin—liver cancer	0.000836	0.00215	CcSEcCtD
Montelukast—Thrombocytopenia—Epirubicin—liver cancer	0.000834	0.00214	CcSEcCtD
Montelukast—Skin disorder—Epirubicin—liver cancer	0.000828	0.00213	CcSEcCtD
Montelukast—Myalgia—Doxorubicin—liver cancer	0.000823	0.00211	CcSEcCtD
Montelukast—Arthralgia—Doxorubicin—liver cancer	0.000823	0.00211	CcSEcCtD
Montelukast—Anxiety—Doxorubicin—liver cancer	0.00082	0.00211	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000817	0.0021	CcSEcCtD
Montelukast—Oedema—Doxorubicin—liver cancer	0.000789	0.00203	CcSEcCtD
Montelukast—Anaphylactic shock—Doxorubicin—liver cancer	0.000789	0.00203	CcSEcCtD
Montelukast—Infection—Doxorubicin—liver cancer	0.000783	0.00201	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000776	0.00199	CcSEcCtD
Montelukast—Nervous system disorder—Doxorubicin—liver cancer	0.000773	0.00199	CcSEcCtD
Montelukast—Thrombocytopenia—Doxorubicin—liver cancer	0.000772	0.00198	CcSEcCtD
Montelukast—Insomnia—Epirubicin—liver cancer	0.000771	0.00198	CcSEcCtD
Montelukast—Skin disorder—Doxorubicin—liver cancer	0.000766	0.00197	CcSEcCtD
Montelukast—Paraesthesia—Epirubicin—liver cancer	0.000765	0.00197	CcSEcCtD
Montelukast—Somnolence—Epirubicin—liver cancer	0.000758	0.00195	CcSEcCtD
Montelukast—Dyspepsia—Epirubicin—liver cancer	0.00075	0.00193	CcSEcCtD
Montelukast—Gastrointestinal disorder—Epirubicin—liver cancer	0.000736	0.00189	CcSEcCtD
Montelukast—Fatigue—Epirubicin—liver cancer	0.000735	0.00189	CcSEcCtD
Montelukast—Pain—Epirubicin—liver cancer	0.000729	0.00187	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000718	0.00185	CcSEcCtD
Montelukast—Insomnia—Doxorubicin—liver cancer	0.000713	0.00183	CcSEcCtD
Montelukast—Paraesthesia—Doxorubicin—liver cancer	0.000708	0.00182	CcSEcCtD
Montelukast—Somnolence—Doxorubicin—liver cancer	0.000701	0.0018	CcSEcCtD
Montelukast—Gastrointestinal pain—Epirubicin—liver cancer	0.000697	0.00179	CcSEcCtD
Montelukast—Dyspepsia—Doxorubicin—liver cancer	0.000694	0.00178	CcSEcCtD
Montelukast—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000681	0.00175	CcSEcCtD
Montelukast—Fatigue—Doxorubicin—liver cancer	0.00068	0.00175	CcSEcCtD
Montelukast—Urticaria—Epirubicin—liver cancer	0.000677	0.00174	CcSEcCtD
Montelukast—Pain—Doxorubicin—liver cancer	0.000674	0.00173	CcSEcCtD
Montelukast—Abdominal pain—Epirubicin—liver cancer	0.000674	0.00173	CcSEcCtD
Montelukast—Body temperature increased—Epirubicin—liver cancer	0.000674	0.00173	CcSEcCtD
Montelukast—Gastrointestinal pain—Doxorubicin—liver cancer	0.000645	0.00166	CcSEcCtD
Montelukast—Hypersensitivity—Epirubicin—liver cancer	0.000628	0.00161	CcSEcCtD
Montelukast—Urticaria—Doxorubicin—liver cancer	0.000626	0.00161	CcSEcCtD
Montelukast—Abdominal pain—Doxorubicin—liver cancer	0.000623	0.0016	CcSEcCtD
Montelukast—Body temperature increased—Doxorubicin—liver cancer	0.000623	0.0016	CcSEcCtD
Montelukast—Asthenia—Epirubicin—liver cancer	0.000611	0.00157	CcSEcCtD
Montelukast—Pruritus—Epirubicin—liver cancer	0.000603	0.00155	CcSEcCtD
Montelukast—Diarrhoea—Epirubicin—liver cancer	0.000583	0.0015	CcSEcCtD
Montelukast—Hypersensitivity—Doxorubicin—liver cancer	0.000581	0.00149	CcSEcCtD
Montelukast—Asthenia—Doxorubicin—liver cancer	0.000566	0.00145	CcSEcCtD
Montelukast—Dizziness—Epirubicin—liver cancer	0.000564	0.00145	CcSEcCtD
Montelukast—Pruritus—Doxorubicin—liver cancer	0.000558	0.00143	CcSEcCtD
Montelukast—Vomiting—Epirubicin—liver cancer	0.000542	0.00139	CcSEcCtD
Montelukast—Diarrhoea—Doxorubicin—liver cancer	0.00054	0.00139	CcSEcCtD
Montelukast—Rash—Epirubicin—liver cancer	0.000537	0.00138	CcSEcCtD
Montelukast—Dermatitis—Epirubicin—liver cancer	0.000537	0.00138	CcSEcCtD
Montelukast—Headache—Epirubicin—liver cancer	0.000534	0.00137	CcSEcCtD
Montelukast—Dizziness—Doxorubicin—liver cancer	0.000521	0.00134	CcSEcCtD
Montelukast—Nausea—Epirubicin—liver cancer	0.000506	0.0013	CcSEcCtD
Montelukast—Vomiting—Doxorubicin—liver cancer	0.000501	0.00129	CcSEcCtD
Montelukast—Rash—Doxorubicin—liver cancer	0.000497	0.00128	CcSEcCtD
Montelukast—Dermatitis—Doxorubicin—liver cancer	0.000497	0.00128	CcSEcCtD
Montelukast—Headache—Doxorubicin—liver cancer	0.000494	0.00127	CcSEcCtD
Montelukast—Nausea—Doxorubicin—liver cancer	0.000468	0.0012	CcSEcCtD
Montelukast—CYSLTR1—Signaling Pathways—H2AFX—liver cancer	0.000179	0.00043	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—IL2—liver cancer	0.000179	0.00043	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—NR1H4—liver cancer	0.000179	0.000429	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—PIK3CB—liver cancer	0.000177	0.000425	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—TAT—liver cancer	0.000176	0.000423	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GSTA3—liver cancer	0.000176	0.000422	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CPT1B—liver cancer	0.000176	0.000421	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GLUL—liver cancer	0.000176	0.000421	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000174	0.000416	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—GSTM1—liver cancer	0.000171	0.000409	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—NR1H4—liver cancer	0.000169	0.000406	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GSTA3—liver cancer	0.000166	0.000399	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000163	0.000391	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—IL2—liver cancer	0.000163	0.00039	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TERT—liver cancer	0.000162	0.000389	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—CYP1A1—liver cancer	0.000162	0.000388	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000162	0.000388	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—UGDH—liver cancer	0.000161	0.000386	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GSTA4—liver cancer	0.000161	0.000386	CbGpPWpGaD
Montelukast—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.000161	0.000386	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000157	0.000377	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GSTA2—liver cancer	0.000157	0.000376	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GSTA4—liver cancer	0.000152	0.000365	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—EPT1—liver cancer	0.000152	0.000363	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GSTA1—liver cancer	0.000151	0.000363	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—MTHFR—liver cancer	0.000151	0.000361	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.00015	0.000359	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—NAT2—liver cancer	0.00015	0.000359	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GSTA2—liver cancer	0.000148	0.000356	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—KDR—liver cancer	0.000148	0.000356	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PPARA—liver cancer	0.000148	0.000355	CbGpPWpGaD
Montelukast—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.000148	0.000355	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MAPK14—liver cancer	0.000147	0.000353	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—ESR1—liver cancer	0.000144	0.000347	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000144	0.000345	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—TAT—liver cancer	0.000144	0.000344	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ALDOB—liver cancer	0.000144	0.000344	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GSTA1—liver cancer	0.000143	0.000343	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—F2—liver cancer	0.000143	0.000342	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000142	0.000341	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—NAT2—liver cancer	0.000142	0.000339	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000141	0.000339	CbGpPWpGaD
Montelukast—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.00014	0.000336	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CRABP1—liver cancer	0.000137	0.000328	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—APC—liver cancer	0.000137	0.000328	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PIK3CG—liver cancer	0.000137	0.000328	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ALDOB—liver cancer	0.000136	0.000325	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.000133	0.000318	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.00013	0.000312	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CRABP1—liver cancer	0.000129	0.00031	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—BRAF—liver cancer	0.000128	0.000308	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PIK3CG—liver cancer	0.000127	0.000304	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000123	0.000296	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PPARG—liver cancer	0.000122	0.000293	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PIK3CD—liver cancer	0.00012	0.000288	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GLUL—liver cancer	0.00012	0.000288	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CPT1B—liver cancer	0.00012	0.000288	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—HPGDS—liver cancer	0.00012	0.000287	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000119	0.000285	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—PIK3CA—liver cancer	0.000119	0.000285	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—SERPINE1—liver cancer	0.000119	0.000285	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—KRAS—liver cancer	0.000118	0.000282	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—NR1H4—liver cancer	0.000116	0.000277	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GSTA3—liver cancer	0.000114	0.000273	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—HPGDS—liver cancer	0.000113	0.000271	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PIK3CD—liver cancer	0.000111	0.000267	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—ALB—liver cancer	0.00011	0.000263	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000108	0.00026	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—PIK3CA—liver cancer	0.000108	0.000259	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—RAF1—liver cancer	0.000107	0.000257	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000107	0.000257	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PSMD10—liver cancer	0.000107	0.000256	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PSMA4—liver cancer	0.000107	0.000256	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—UGDH—liver cancer	0.000106	0.000255	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000106	0.000254	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MTOR—liver cancer	0.000105	0.000251	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PIK3CB—liver cancer	0.000105	0.000251	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GSTA4—liver cancer	0.000104	0.000249	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GOT2—liver cancer	0.000104	0.000249	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000102	0.000244	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GSTA2—liver cancer	0.000101	0.000243	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PSMA4—liver cancer	0.000101	0.000242	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PSMD10—liver cancer	0.000101	0.000242	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—HRAS—liver cancer	9.99e-05	0.00024	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—EPT1—liver cancer	9.99e-05	0.00024	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CDKN1B—liver cancer	9.82e-05	0.000236	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GOT2—liver cancer	9.81e-05	0.000235	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GSTA1—liver cancer	9.78e-05	0.000235	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CPT1B—liver cancer	9.76e-05	0.000234	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GLUL—liver cancer	9.76e-05	0.000234	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CYP2E1—liver cancer	9.76e-05	0.000234	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—AKT1—liver cancer	9.72e-05	0.000233	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PIK3CB—liver cancer	9.7e-05	0.000233	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—NAT2—liver cancer	9.67e-05	0.000232	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CASP3—liver cancer	9.63e-05	0.000231	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IL2—liver cancer	9.61e-05	0.000231	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—IL6—liver cancer	9.56e-05	0.000229	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—TAT—liver cancer	9.47e-05	0.000227	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	9.45e-05	0.000227	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—NR1H4—liver cancer	9.41e-05	0.000226	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CCND1—liver cancer	9.37e-05	0.000225	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—JUN—liver cancer	9.35e-05	0.000224	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—liver cancer	9.3e-05	0.000223	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CTNNB1—liver cancer	9.28e-05	0.000223	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ALDOB—liver cancer	9.27e-05	0.000222	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GSTA3—liver cancer	9.26e-05	0.000222	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CYP2E1—liver cancer	9.23e-05	0.000221	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CYCS—liver cancer	9.13e-05	0.000219	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MMP9—liver cancer	9.1e-05	0.000218	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CDKN1A—liver cancer	9.06e-05	0.000217	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GGT1—liver cancer	8.96e-05	0.000215	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GOT1—liver cancer	8.96e-05	0.000215	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MAPK8—liver cancer	8.85e-05	0.000212	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CRABP1—liver cancer	8.84e-05	0.000212	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—AKT1—liver cancer	8.82e-05	0.000212	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CYCS—liver cancer	8.63e-05	0.000207	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GOT1—liver cancer	8.47e-05	0.000203	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GGT1—liver cancer	8.47e-05	0.000203	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GSTA4—liver cancer	8.47e-05	0.000203	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	8.27e-05	0.000198	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GSTA2—liver cancer	8.25e-05	0.000198	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—VEGFA—liver cancer	8.17e-05	0.000196	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—STAT3—liver cancer	8.09e-05	0.000194	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GSTP1—liver cancer	8.05e-05	0.000193	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	7.96e-05	0.000191	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GSTA1—liver cancer	7.96e-05	0.000191	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—HMOX1—liver cancer	7.93e-05	0.00019	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—NAT2—liver cancer	7.87e-05	0.000189	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—HPGDS—liver cancer	7.73e-05	0.000185	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	7.69e-05	0.000184	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GSTP1—liver cancer	7.61e-05	0.000182	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	7.57e-05	0.000181	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ALDOB—liver cancer	7.54e-05	0.000181	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MYC—liver cancer	7.52e-05	0.00018	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—HMOX1—liver cancer	7.5e-05	0.00018	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TGFB1—liver cancer	7.5e-05	0.00018	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GSTM1—liver cancer	7.39e-05	0.000177	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CRABP1—liver cancer	7.2e-05	0.000173	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CYP1A1—liver cancer	7.01e-05	0.000168	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	7e-05	0.000168	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GSTM1—liver cancer	6.99e-05	0.000168	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—KRAS—liver cancer	6.94e-05	0.000167	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	6.91e-05	0.000166	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PSMD10—liver cancer	6.89e-05	0.000165	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PSMA4—liver cancer	6.89e-05	0.000165	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GOT2—liver cancer	6.7e-05	0.000161	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CYP1A1—liver cancer	6.63e-05	0.000159	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—MTHFR—liver cancer	6.53e-05	0.000157	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	6.48e-05	0.000155	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CPT1B—liver cancer	6.44e-05	0.000154	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GLUL—liver cancer	6.44e-05	0.000154	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PPARA—liver cancer	6.41e-05	0.000154	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PIK3CA—liver cancer	6.38e-05	0.000153	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP2E1—liver cancer	6.3e-05	0.000151	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—HPGDS—liver cancer	6.29e-05	0.000151	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	6.25e-05	0.00015	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—NR1H4—liver cancer	6.21e-05	0.000149	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—MTHFR—liver cancer	6.18e-05	0.000148	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TP53—liver cancer	6.17e-05	0.000148	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GSTA3—liver cancer	6.1e-05	0.000146	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	6.1e-05	0.000146	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PPARA—liver cancer	6.06e-05	0.000145	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PIK3CA—liver cancer	5.91e-05	0.000142	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—HRAS—liver cancer	5.9e-05	0.000142	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYCS—liver cancer	5.9e-05	0.000141	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GOT1—liver cancer	5.79e-05	0.000139	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GGT1—liver cancer	5.79e-05	0.000139	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.76e-05	0.000138	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	5.7e-05	0.000137	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IL6—liver cancer	5.65e-05	0.000135	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	5.62e-05	0.000135	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PSMD10—liver cancer	5.61e-05	0.000134	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PSMA4—liver cancer	5.61e-05	0.000134	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GSTA4—liver cancer	5.58e-05	0.000134	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PIK3CG—liver cancer	5.49e-05	0.000132	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GOT2—liver cancer	5.45e-05	0.000131	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GSTA2—liver cancer	5.44e-05	0.00013	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PPARG—liver cancer	5.3e-05	0.000127	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GSTA1—liver cancer	5.25e-05	0.000126	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—AKT1—liver cancer	5.21e-05	0.000125	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GSTP1—liver cancer	5.2e-05	0.000125	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PIK3CG—liver cancer	5.19e-05	0.000124	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—NAT2—liver cancer	5.19e-05	0.000124	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP2E1—liver cancer	5.13e-05	0.000123	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—HMOX1—liver cancer	5.13e-05	0.000123	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PPARG—liver cancer	5.01e-05	0.00012	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ALDOB—liver cancer	4.98e-05	0.000119	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.97e-05	0.000119	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—AKT1—liver cancer	4.83e-05	0.000116	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PIK3CD—liver cancer	4.83e-05	0.000116	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYCS—liver cancer	4.8e-05	0.000115	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GSTM1—liver cancer	4.78e-05	0.000115	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ALB—liver cancer	4.76e-05	0.000114	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CRABP1—liver cancer	4.75e-05	0.000114	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GGT1—liver cancer	4.71e-05	0.000113	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GOT1—liver cancer	4.71e-05	0.000113	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PIK3CD—liver cancer	4.56e-05	0.000109	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP1A1—liver cancer	4.53e-05	0.000109	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ALB—liver cancer	4.51e-05	0.000108	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GSTP1—liver cancer	4.23e-05	0.000101	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—MTHFR—liver cancer	4.22e-05	0.000101	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PIK3CB—liver cancer	4.21e-05	0.000101	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—HMOX1—liver cancer	4.17e-05	0.0001	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—HPGDS—liver cancer	4.15e-05	9.95e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PPARA—liver cancer	4.14e-05	9.93e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PIK3CB—liver cancer	3.98e-05	9.54e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GSTM1—liver cancer	3.89e-05	9.32e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.72e-05	8.92e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PSMA4—liver cancer	3.7e-05	8.87e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PSMD10—liver cancer	3.7e-05	8.87e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP1A1—liver cancer	3.68e-05	8.84e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GOT2—liver cancer	3.6e-05	8.63e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PIK3CG—liver cancer	3.55e-05	8.5e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—MTHFR—liver cancer	3.44e-05	8.24e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PPARG—liver cancer	3.42e-05	8.21e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP2E1—liver cancer	3.38e-05	8.11e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PPARA—liver cancer	3.37e-05	8.08e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYCS—liver cancer	3.16e-05	7.59e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PIK3CD—liver cancer	3.12e-05	7.48e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GOT1—liver cancer	3.11e-05	7.45e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GGT1—liver cancer	3.11e-05	7.45e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ALB—liver cancer	3.08e-05	7.38e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.03e-05	7.26e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PIK3CG—liver cancer	2.89e-05	6.92e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GSTP1—liver cancer	2.79e-05	6.69e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PPARG—liver cancer	2.79e-05	6.68e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—HMOX1—liver cancer	2.75e-05	6.6e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PIK3CB—liver cancer	2.72e-05	6.52e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PIK3CA—liver cancer	2.56e-05	6.15e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GSTM1—liver cancer	2.56e-05	6.15e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PIK3CD—liver cancer	2.54e-05	6.08e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ALB—liver cancer	2.5e-05	6.01e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP1A1—liver cancer	2.43e-05	5.83e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PIK3CA—liver cancer	2.42e-05	5.82e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—MTHFR—liver cancer	2.27e-05	5.43e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PPARA—liver cancer	2.22e-05	5.33e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PIK3CB—liver cancer	2.21e-05	5.3e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—AKT1—liver cancer	2.09e-05	5.02e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—AKT1—liver cancer	1.98e-05	4.75e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PIK3CG—liver cancer	1.9e-05	4.56e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PPARG—liver cancer	1.84e-05	4.41e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PIK3CD—liver cancer	1.67e-05	4.01e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PIK3CA—liver cancer	1.66e-05	3.97e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ALB—liver cancer	1.65e-05	3.96e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PIK3CB—liver cancer	1.46e-05	3.5e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—AKT1—liver cancer	1.35e-05	3.24e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PIK3CA—liver cancer	1.35e-05	3.23e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—AKT1—liver cancer	1.1e-05	2.64e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PIK3CA—liver cancer	8.89e-06	2.13e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—AKT1—liver cancer	7.26e-06	1.74e-05	CbGpPWpGaD
